Human papillomavirus (HPV) vaccination represents one of the greatest opportunities to prevent cancer before it ever develops.
Awareness Still Lags Behind the ScienceHistorically, conversations surrounding HPV vaccination have largely occurred in pediatric and primary care settings.
Framing the HPV vaccine as cancer prevention rather than as protection from a sexually transmitted infection changes the conversation.
Oncology Nurses Influence More Than Current PatientsThe influence of oncology nursing extends well beyond the individual sitting in the infusion chair.
Whether through patient education, advocacy, interdisciplinary collaboration, or simply reframing conversations around cancer prevention, nursing voices remain powerful.
Human papillomavirus (HPV) vaccination represents one of the greatest opportunities to prevent cancer before it ever develops. Despite overwhelming evidence supporting its safety and effectiveness, public understanding of HPV remains inconsistent. Recent public health data continue to demonstrate that many adults do not recognize HPV as a cause of multiple cancers, while vaccination progress has slowed nationally despite years of recommendations and public health campaigns.
For oncology nurses, this knowledge gap matters. Every patient diagnosed with an HPV-related cancer reminds us that prevention opportunities exist long before treatment begins.
Awareness Still Lags Behind the Science
Historically, conversations surrounding HPV vaccination have largely occurred in pediatric and primary care settings. Yet, oncology nurses witness the downstream consequences every day caring for patients with cervical cancer, HPV-associated anal cancers, and increasingly, patients with HPV-positive oropharyngeal cancers.
By the time these patients enter oncology, prevention has already become treatment.
HPV is responsible for the vast majority of cervical cancers and contributes to cancers of the oropharynx, anus, vulva, vagina, and penis. The CDC estimates that HPV causes approximately 36,000 cancers each year in the US and that vaccination could prevent more than 90% of these cancers.
HPV-associated oropharyngeal cancer has become one of the most common HPV-related cancers in the US, particularly among men. Unlike cervical cancer, where organized screening guidelines and programs exist, many HPV-positive head and neck cancers are diagnosed only after symptoms develop. This shift makes primary prevention through vaccination even more important. Despite this, awareness remains incomplete.
Many adults continue to associate HPV exclusively with cervical cancer, or fail to recognize its connection to cancer altogether. Public health surveys have demonstrated persistent knowledge gaps regarding HPV-related cancer risk, highlighting that scientific advances alone are insufficient without effective communication.
Knowledge changes behavior, and behavior changes outcomes.
The Recommendation That Matters Most
Research demonstrates that healthcare provider recommendation remains one of the strongest predictors of HPV vaccine acceptance. Parents consistently identify clinicians as their most trusted source of vaccine information, and adolescents are significantly more likely to receive HPV vaccination when a healthcare professional provides a strong, routine recommendation.
That recommendation does not have to be lengthy, but it has to be confident.
Framing the HPV vaccine as cancer prevention rather than as protection from a sexually transmitted infection changes the conversation. Families are far more likely to understand the long-term benefit when the discussion centers on preventing future cancers rather than preventing infection.
Language matters.
Oncology Nurses Influence More Than Current Patients
The influence of oncology nursing extends well beyond the individual sitting in the infusion chair. Patients ask whether their children or grandchildren should receive the HPV vaccine. Family members accompany them to appointments. A cancer diagnosis often becomes a teachable moment that reshapes an entire family’s understanding of prevention.
These conversations are not outside the scope of oncology nursing. They are extensions of patient education.
When appropriate, nurses can encourage patients and caregivers to discuss HPV vaccination with their primary care provider or pediatrician, reinforcing evidence-based recommendations without stepping outside their professional role.
Expanding Access Requires Expanding Partnerships
Improving HPV vaccination rates will require more than physician offices alone. Meaningful progress depends on coordinated efforts across the healthcare continuum, including primary care, pharmacies, schools, public health agencies, community organizations, and health systems working together to reduce barriers and expand access. Reducing barriers to vaccination is an important component of comprehensive cancer prevention strategies.
Access is rarely a single problem. It is the cumulative effect of convenience, education, trust, and opportunity.
Oncology nurses understand this better than most because we spend our careers navigating barriers that prevent patients from receiving timely cancer care.
The same principles apply to prevention.
Prevention Is Still The Best Treatment
Modern oncology is often defined by increasingly sophisticated therapies. But one of the greatest successes in cancer care is preventing the disease from occurring in the first place. Every prevented HPV-related cancer represents a patient who never needs chemotherapy. Never needs radiation. Never hears the words, “You have cancer.”
That is a remarkable outcome.
Nurses are positioned to bridge the gap between public awareness and scientific evidence. Whether through patient education, advocacy, interdisciplinary collaboration, or simply reframing conversations around cancer prevention, nursing voices remain powerful.
The future of oncology is not only about delivering better cancer treatment. It is also about ensuring fewer people ever need it.
